MRAI Marpai, Inc.
Services-Misc Health & Allied Services, NEC · OTC · SEC CIK 1844392 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-17.8%
TTM net income YoY-37.9%
TTM EPS YoY-6.2%
Revenue 3-yr CAGR-22.1%
Net income 3-yr CAGR—
Margins
Gross margin25.0%
Operating margin-78.4%
Net margin-98.0%
FCF margin—
EBITDA margin-77.7%
Returns
ROE—
ROA-141.5%
ROIC (approx.)—
Asset turnover1.44x
Leverage & solvency
Liabilities / assets375.3%
Debt / equity—
Current ratio0.65x
Interest coverage-3.64x
Cash quality & payout
Operating cash flow / net income0.98x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $18.10M | $28.17M | $37.16M | $24.34M | $14.23M |
| Cost of revenue | $13.32M | $19.07M | $24.24M | $17.14M | $10.29M |
| Gross profit | $4.78M | $9.11M | $12.92M | $7.21M | $3.94M |
| R&D expense | $7,000 | $29,000 | $1.31M | $3.71M | $1.73M |
| SG&A expense | $11.14M | $12.83M | $19.18M | $12.32M | $8.06M |
| Operating income | -$13.55M | -$22.09M | -$27.98M | -$26.96M | -$15.86M |
| Interest expense | $3.23M | $2.71M | $1.53M | $266,778 | $427,178 |
| Pretax income | -$16.56M | -$23.28M | -$29.04M | -$26.99M | -$16.13M |
| Income tax | — | -$1.19M | -$290,000 | -$521,132 | -$150,000 |
| Net income | -$16.56M | -$22.09M | -$28.75M | -$26.47M | -$15.98M |
| EBITDA | -$13.17M | -$19.83M | -$24.08M | -$23.42M | -$13.90M |
| EPS (basic) | -0.95 | -1.92 | -4.14 | -5.23 | -1.59 |
| EPS (diluted) | -0.95 | -1.92 | -4.14 | -5.23 | -1.59 |
| Weighted avg. shares (diluted) | 17.37M | 11.51M | 6.95M | 5.06M | 10.08M |
| Balance sheet | |||||
| Cash & equivalents | $133,000 | $9.23M | $13.49M | $23.12M | $25.93M |
| Receivables | $697,000 | $837,000 | $1.12M | $1.44M | $208,762 |
| Current assets | $10.34M | $11.90M | $17.09M | $26.54M | $26.99M |
| PP&E, net | $0 | $0 | $611,000 | $1.51M | $889,935 |
| Goodwill | — | — | $3.02M | $3.02M | $2.38M |
| Intangibles | $60,000 | $441,000 | $5.18M | $6.32M | $5.51M |
| Total assets | $10.90M | $12.88M | $31.68M | $49.95M | $44.20M |
| Current liabilities | $25.69M | $18.98M | $20.84M | $17.36M | $11.15M |
| Short-term debt | $8.00M | $6.10M | $600,000 | — | — |
| Long-term debt | $19.40M | $17.79M | $19.40M | $20.20M | $0 |
| Total debt | $27.40M | $23.89M | $20.00M | $20.20M | $0 |
| Total liabilities | $43.47M | $40.59M | $45.12M | $43.82M | $14.49M |
| Shareholders' equity | -$32.56M | -$27.71M | -$13.44M | $6.13M | $29.71M |
| Net debt | $27.27M | $14.66M | $6.51M | -$2.91M | -$25.93M |
| Shares outstanding | 24.04M | 14.24M | 7.96M | 5.32M | 20.30M |
| Cash flow statement | |||||
| Operating cash flow | -$7.45M | -$15.16M | -$15.75M | -$35.24M | -$10.80M |
| Capital expenditure | — | — | — | $362,768 | $273,433 |
| Free cash flow | — | — | — | -$35.60M | -$11.07M |
| Investing cash flow | $500,000 | $227,000 | $1.03M | $32.42M | $9.64M |
| Financing cash flow | $6.67M | $10.67M | $5.10M | $196 | $25.27M |
| Depreciation & amortization | $381,000 | $2.26M | $3.90M | $3.54M | $1.96M |
| Stock-based compensation | $3.61M | $3.16M | $2.10M | $3.11M | $1.23M |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.